论文部分内容阅读
目的观察丹参注射液联合依达拉奉治疗急性脑梗死的临床疗效。方法将120例急性脑梗死患者根据随机数字表法随机分为观察组和对照组,每组60例。2组患者均给予常规治疗,对照组患者采用依达拉奉治疗,观察组采用丹参注射液联合依达拉奉治疗。治疗后观察2组患者的临床疗效及不良反应发生情况。对比治疗前后2组患者的血液流变学指标变化。结果治疗后观察组患者总有效率高于对照组;2组治疗后患者的全血高切黏度、全血低切黏度、血浆黏度及红细胞压积均低于治疗前,且观察组低于对照组,差异均有统计学意义(P<0.05)。2组患者均出现恶心、呕吐1例,后逐渐恢复正常。结论丹参注射液联合依达拉奉治疗急性脑梗死效果较好,血液流变学指标显著改善,不良反应少,值得临床推广应用。
Objective To observe the clinical effect of Salvia miltiorrhiza injection combined with edaravone in the treatment of acute cerebral infarction. Methods 120 patients with acute cerebral infarction were randomly divided into observation group and control group according to random number table method, each group 60 cases. The patients in both groups were given routine treatment. The patients in the control group were treated with edaravone. The observation group was treated with Danshen injection combined with edaravone. After treatment, the clinical efficacy and adverse reactions of the two groups were observed. The changes of hemorheology indexes in two groups before and after treatment were compared. Results After treatment, the total effective rate of the observation group was higher than that of the control group. The high blood viscosity, the low blood viscosity, the plasma viscosity and the hematocrit of the two groups after treatment were lower than those before treatment, and the observation group was lower than the control group Group, the difference was statistically significant (P <0.05). In both groups, nausea and vomiting occurred in 1 patient and gradually returned to normal. Conclusion Danshen injection combined with edaravone in the treatment of acute cerebral infarction better, hemorheological indicators significantly improved, fewer adverse reactions, it is worthy of clinical application.